Legis Daily

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022

USA117th CongressHR-8724| House 
| Updated: 8/16/2022
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (16)
Danny K. Davis (Democratic)Lucille Roybal-Allard (Democratic)Ro Khanna (Democratic)Ann M. Kuster (Democratic)André Carson (Democratic)Alma S. Adams (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Nydia M. Velázquez (Democratic)Yvette D. Clarke (Democratic)Earl Blumenauer (Democratic)Nanette Diaz Barragán (Democratic)Gwen Moore (Democratic)Grace Meng (Democratic)Veronica Escobar (Democratic)Judy Chu (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022 This bill requires the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in menstrual products and intimate care products pose health risks to people who use the products or to the children of people who use the products during or before pregnancy.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Aug 16, 2022
Introduced in House
Aug 16, 2022
Referred to the House Committee on Energy and Commerce.
  • August 16, 2022
    Introduced in House


  • August 16, 2022
    Referred to the House Committee on Energy and Commerce.

Health

Child healthHazardous wastes and toxic substancesMedical researchResearch administration and fundingSex and reproductive healthWomen's health

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022

USA117th CongressHR-8724| House 
| Updated: 8/16/2022
Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022 This bill requires the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in menstrual products and intimate care products pose health risks to people who use the products or to the children of people who use the products during or before pregnancy.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Aug 16, 2022
Introduced in House
Aug 16, 2022
Referred to the House Committee on Energy and Commerce.
  • August 16, 2022
    Introduced in House


  • August 16, 2022
    Referred to the House Committee on Energy and Commerce.
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (16)
Danny K. Davis (Democratic)Lucille Roybal-Allard (Democratic)Ro Khanna (Democratic)Ann M. Kuster (Democratic)André Carson (Democratic)Alma S. Adams (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Nydia M. Velázquez (Democratic)Yvette D. Clarke (Democratic)Earl Blumenauer (Democratic)Nanette Diaz Barragán (Democratic)Gwen Moore (Democratic)Grace Meng (Democratic)Veronica Escobar (Democratic)Judy Chu (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Child healthHazardous wastes and toxic substancesMedical researchResearch administration and fundingSex and reproductive healthWomen's health